Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PHEBURANE 350 MG/ML SOLUCION ORAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/PHEBURANE 350 MG/ML SOLUCION ORAL

Approved

STANDARD

PHEBURANE 350 MG/ML SOLUCION ORAL

Eurocept International B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 18, 2024
Approval ID: 99d101201d47cf78
Company: Eurocept International B.V.
Type: Standard

Approval Details

Approval Id: 99d101201d47cf78
Drug Cima Aemps Name: PHEBURANE 350 MG/ML SOLUCION ORAL
Register Number: 113822006
Holder Company Name: Eurocept International B.V.
Marketing Company Name: Eurocept International B.V.
Holder Company Detail Path: /organization/eurocept-international-b-v
Marketing Company Detail Path: /organization/eurocept-international-b-v
Authorization Date: 2024-03-18
Dosage Form: SOLUCIÓN ORAL
Dose: 350 mg/ml
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Eurocept International B.V.
Company Detail Path: /organization/eurocept-international-b-v

Company Information

Pharmaceutical Company Name: Eurocept International B.V.

Active Ingredients

FENILBUTIRATO SODIO

350 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 18, 2024

Approval ID

99d101201d47cf78

Type

Standard

Back to CIMA-AEMPS Approvals